Skip to content
Country / language

Country / language

  • Belgium
  • Switzerland

Your profile

Non-professional investor

European value equities

DNCA Invest Value Europe

Value

  • Life insurance
  • PEA
SFDR Article 8

Key points

A selection of mainly European stocks with a value bias.

  • A portfolio comprised of undervalued European stocks that, according to the management team, offer significant appreciation potential.
  • An experienced, international management team.
  • A disciplined investment process with financial and non-financial analysis of issuers.

Managers comments · October 2026

4 minutes

Following the sharp decline in European stock indices in September, October was marked by a resurgence of risk aversion and a pronounced rotation among sectors (with the Stoxx Europe 600 rising by +1.9%). Geopolitical tensions in the Middle East fueled rising oil prices and inflationary pressures, while concerns about the financing of artificial intelligence-related investments weighed on the technology sector and, more specifically, on semiconductors. Against this backdrop, the broader European market held up better than the U.S. markets (the S&P 500 fell 0.9%) and Japanese markets (the Nikkei 225 fell 5.2%), though there were significant disparities among countries, sectors, and individual stocks.

Sovereign tensions remained particularly pronounced in France. Political, fiscal, and social uncertainties pushed the yield on the 10-year OAT to around 5% during the month and widened the spread with the German Bund. This development weighed on domestic assets and banks, whose bond portfolios are sensitive to widening spreads.

On the economic front, however, the eurozone posted 0.4% growth in the third quarter—exceeding expectations—and a composite PMI of 51.9 in October, still consistent with moderate expansion. In the United States, annualized growth of 3.4% and a composite PMI of 57.6 confirmed significantly stronger economic activity. Against this backdrop, central banks' decisions regarding interest rate hikes remain uncertain.

Sector rotation was very pronounced over the month. Healthcare (+14.1%), food (+13.1%), and oil (+8.7%) posted the best sector performances, benefiting from solid earnings reports, a sought-after defensive profile, and—in the case of energy—rising oil prices. Conversely, banks (-10.6%) and commodities (-8.5%) fell sharply. Technology lost 1.5%, but this average decline masks a much steeper correction in semiconductors, which were affected by concerns over the financing of the AI ecosystem and the profitability of capital expenditures.

Earnings season provided some support to the market, though it did not dispel macroeconomic concerns. Earnings reports confirmed the strength of several healthcare and consumer staples companies, while high expectations made technology stocks more vulnerable to disappointments. The environment therefore favored stock selection and sector diversification over uniform directional risk-taking.

Over the past month, the fund posted a return of 1.96%, in line with its benchmark, the Stoxx Europe 600 Net Return. The portfolio allocation reflects the sectoral dispersion mentioned above: healthcare, consumer staples, and energy stocks supported the portfolio, while banks, metals, and seeds were the main drag.

Among the positive contributors to performance in October were Capgemini (+61bp), Roche (+38bp), and Heineken (+28bp).

Capgemini was supported in particular by Accenture's earnings, which reassured investors about the resilience of IT budgets and demand for consulting, cloud, and AI services. Roche benefited from the sector's strong rebound. Heineken, in addition to its sought-after defensive profile, benefited from a solid quarterly report, marked by a 4.8% increase in volumes.

Among the main drag on the index were Aperam (-41bp), Edenred (-29bp), and Infineon (-26bp). Aperam was the biggest drag, in an environment that was highly unfavorable for metals and cyclical stocks. Infineon suffered from the broad-based decline in semiconductors. Finally, despite operating revenue that was slightly above expectations, the market penalized Edenred for the slowdown in its underlying business and guidance that was already largely priced in.

Text completed on 17/11/2026 · Isaac Chebar, Julie Arav, Maxime Genevois, CFA, Boris Radondy, CFA

NAV

As of 16/11/2026

€384.42
Net asset value over 1 year

Risk Indicator

Synthetic risk indicator according to PRIIPS. 1 corresponds to the lowest level and 7 to the highest level.

Risks

  • Equity risk
  • Risk related to exchange rate
  • Risk of capital loss
  • Risk relating to investments in derivative products
  • Sustainability risk
  • ESG risk

Performance and volatility

As of 16/11/2026

Year-to-date performance
+16.89%
Performance 2025
+23.19%
Performance 5 years annualized
+12.72%
Performance 5 years
+82.00%
Volatility over 5 years
14.27%

Breakdown by country

As of 30/09/2026

Performance

As of 16/11/2026

    • New investment strategy and investment objective

Portfolio Managers

Isaac Chebar

European equity portfolio manager

Isaac Chebar holds a chemical engineering degree from the Polytechnic school of the University of Sao Paolo in Brazil.

He began his career at Société Générale managing emerging market funds and funds investing in Southern Europe. In 2000, Isaac joined Tocqueville Finance where he set up and managed Tocqueville Value Europe until 2002. He then joined Aviva asset management as head of European investments managing several discretionary funds.

He joined the DNCA Finance management team in 2007.

Footnotes

Legal information

DNCA Investments uses consent cookies for audience measurement purposes in order to produce anonymous statistics. You can object to the use of these cookies by clicking on the "Refuse all" button. For more information, please visit our dedicated page.

For any questions regarding the collection or processing of your personal data, including those collected through cookies, please see our "Your personal data" page or send us your request through its online form.